Predictors of Immunomodulator Use as Early Therapy in Pediatric Crohn's Disease
暂无分享,去创建一个
[1] R. Baldassano,et al. Is an Abbreviated Pediatric Crohn's Disease Activity Index Better Than the Original? , 2004, Journal of pediatric gastroenterology and nutrition.
[2] R. Hoffmann,et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. , 2003, The Journal of pediatrics.
[3] A. Griffiths,et al. A Critical Assessment of Items on the Pediatric Crohn's Disease Activity Index , 2003, Journal of pediatric gastroenterology and nutrition.
[4] H. Büller,et al. Treatment of inflammatory bowel disease in childhood: best available evidence. , 2003, Inflammatory bowel diseases.
[5] J. Markowitz,et al. Immunomodulatory therapy for pediatric inflammatory bowel disease: changing patterns of use, 1990–2000 , 2002, American Journal of Gastroenterology.
[6] J. Markowitz,et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. , 2000, Gastroenterology.
[7] J. Schwartz,et al. Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma. , 2000, Gastroenterology.
[8] R. Baldassano,et al. Inflammatory bowel disease in pediatric and adolescent patients. , 1999, Gastroenterology clinics of North America.
[9] M. Peppercorn,et al. UC cancers in PSC: Right sided or wrong? , 1998 .
[10] B. Kirschner,et al. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. , 1998, Gastroenterology.
[11] E. Seidman,et al. Controversies in Pediatric Inflammatory Bowel Disease , 1998 .
[12] Y. Théorêt,et al. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. , 1996, Gut.
[13] W. Sandborn. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. , 1996, The American journal of gastroenterology.
[14] J. Markowitz,et al. Growth failure in pediatric inflammatory bowel disease. , 1993, Journal of pediatric gastroenterology and nutrition.
[15] H. Hildebrand,et al. Chronic Inflammatory Bowel Disease in Children and Adolescents in Sweden , 1991, Journal of pediatric gastroenterology and nutrition.
[16] J T Boyle,et al. Development and validation of a pediatric Crohn's disease activity index. , 1991, Journal of pediatric gastroenterology and nutrition.
[17] J. Markowitz,et al. Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease. , 1990, Gastroenterology.
[18] S. Meltzer,et al. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. , 1989, Annals of internal medicine.
[19] K. Ewe,et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. , 1984, Gastroenterology.
[20] B. Pasternack,et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. , 1980, The New England journal of medicine.
[21] R. Summers,et al. National Cooperative Crohn's Disease Study: results of drug treatment. , 1979, Gastroenterology.
[22] H. Spiro,et al. Treatment of Crohn's disease with azathioprine: a controlled evaluation. , 1974, Gastroenterology.
[23] G. Keele. Letter: Rubella vaccination. , 1973, Lancet.
[24] D. Bainton,et al. Controlled trial of azathioprine in Crohn's disease. , 1971, Lancet.